New Drugs Targeting Antibiotic-Resistant Bacteria: Recent Advances examines the molecular, pharmacological, and clinical dimensions of resistance development and highlights innovative therapeutic approaches aimed at overcoming multidrug-resistant organisms (MDROs), providing an in-depth exploration of emerging strategies to combat one of the most urgent public health challenges of our time—antimicrobial resistance (AMR). Beginning with the mechanisms underlying bacterial resistance such as β-lactamase production, efflux pump activity, and membrane protein modification, the text underscores the growing threat posed by ESKAPE pathogens and CDC-classified priority infections. Chapters also explore cutting-edge interventions including bacteriophage therapy, discovery of novel antibacterial compounds from natural sources, and the use of nanoparticles and quorum-sensing inhibitors to suppress bacterial virulence. Further sections discuss carbapenemase-mediated resistance, emphasizing enzyme classification, detection strategies, and the importance of clinical microbiology in guiding antibiotic stewardship. By integrating one-health perspectives that consider human, animal, and environmental dimensions, this book presents a holistic roadmap for addressing resistance evolution through innovation and responsible antibiotic use. Key Features Examines the molecular mechanisms driving antibiotic resistance in key bacterial species Explores bacteriophage therapy as a promising alternative to conventional antimicrobials Discovers natural-source compounds and novel drug leads for future antibiotic development Analyses carbapenemase-mediated resistance and clinical detection techniques Evaluates new therapeutic approaches including nanoparticle-based treatments and quorum-sensing inhibition Promotes the one-health approach to tackling multidrug-resistant organisms globally

Technical Advances in Pharmacy: An Overview examines the convergence of digital transformation, automation, and data intelligence in revolutionizing drug discovery, formulation, and healthcare delivery Across twelve in-depth chapters the book presents a forward-looking exploration of how emerging technologies are reshaping the landscape of pharmaceutical sciences. The book also covers cutting-edge developments such as artificial intelligence in drug discovery, pharmacogenomics and personalized medicine, blockchain in pharmaceutical supply chains, 3D printing of dosage forms, tele pharmacy, data analytics, and automation in pharmacy practice. By integrating computational modelling with experimental techniques, the text highlights the translational potential of modern technologies in enhancing drug development, patient adherence, and clinical outcomes. Serving as both a reference and a roadmap, this volume bridges traditional pharmaceutical foundations with next-generation innovations, offering readers an insightful perspective on the technological evolution shaping the future of pharmacy. Key Features Examines the role of artificial intelligence, pharmacogenomics, and data analytics in modern drug discovery. Explores blockchain, automation, and robotics as enablers of efficient and transparent pharmacy systems. Integrates computational modeling with experimental approaches for enhanced drug formulation and testing. Highlights 3D printing, telepharmacy, and RegTech as transformative tools in pharmaceutical innovation. Bridges classical pharmaceutical sciences with emerging digital and biotechnological advancements.

Continuing on the groundbreaking discussion on next-generation mucosal vaccines, Mucosal Vaccine Delivery Systems: The Future of Immunization – Part II highlights innovations that redefine preventive healthcare and immunotherapy. By integrating research insights with translational applications, this volume examines the latest progress in mucosal delivery routes, immunological responses, and technological advances that enhance vaccine stability, efficacy, and accessibility . The book draws on global expertise to explore nasal, oral, pulmonary, and urogenital vaccination systems, offering perspectives on formulation strategies, immune modulation, and delivery optimization. It also discusses evolving regulatory frameworks, emerging biotechnological tools, and the socioeconomic impact of widespread mucosal vaccine adoption. Key Features Examines advances in mucosal vaccine platforms and immune mechanisms. Explores innovative delivery routes enhancing patient compliance and protection. Addresses challenges in formulation, stability, and large-scale production. Evaluates regulatory and commercial trends shaping vaccine deployment. Highlights translational research bridging laboratory discovery and clinical application.

Bridging the fields of pharmacy, biotechnology, dermatology, and cosmetic science, this book offers a multidisciplinary perspective on innovation, efficacy, and safety in the development of next-generation beauty and personal care products. The book discusses emerging technologies such as nanoformulations, artificial intelligence, gene therapy, personalized medicine, and peptide science. It addresses their transformative role in cosmetic product development-from skin and hair care to sun protection, anti-aging solutions, and mood-enhancing formulations. Readers will also gain insights into regulatory frameworks, clinical studies, and intellectual property considerations, making this a practical guide for both innovation and compliance in the beauty-tech space. Key Features: Explores integration of pharmaceutical techniques in cosmetic formulation Highlights nano-carriers, AI tools, and gene-based therapies in product development Details the role of natural and herbal ingredients in modern skin and hair care Covers peptide technologies for anti-aging and skin rejuvenation Addresses personalized medicine and pharmacogenomics in cosmetics Reviews regulatory challenges, clinical validation, and patent strategies

Third Generation Ionic Liquids: Synthesis to Applications is an enquiry into the evolution, functional design, and multidisciplinary applications of next-generation ionic liquids. The book focuses on third generation ionic liquids, exploring themes such as novel synthesis routes, structure-property relationships, tunability, and integration into industrial and pharmaceutical systems. It spans major topic areas including supported ionic liquid phases (SILPs), catalysis, green solvents, electrochemical systems, and biomedical interfaces. By bridging fundamental chemistry with real-world applications, the volume supports innovation in green chemistry, energy systems, and advanced materials. Key features: Illustrates synthesis pathways and functionalization techniques Explains structure-performance correlations Demonstrates applications in catalysis, electrochemistry, and CO₂ capture Highlights environmental, toxicological, and regulatory aspects Includes expert contributions and interdisciplinary case studies.

Advances in the Medicinal Chemistry of Neglected Tropical Disease and Related Infectious Diseases offers an in-depth overview of recent progress in drug discovery targeting some of the world’s most persistent and under-researched diseases. With a focus on medicinal chemistry and target-based drug design, this book explores critical pharmacological targets and innovative compounds aimed at combating neglected tropical diseases (NTDs) and related infections.Spread across ten chapters, the book examines the current state and future directions of therapeutic research for diseases such as leishmaniasis, Chagas disease, sleeping sickness, malaria, schistosomiasis, dengue, Zika virus, tuberculosis, and fascioliasis. Each chapter provides details about disease-specific targets, structural activity relationships (SAR), and developments in promising lead compounds over the past decade. Key features: Focuses on pharmacological targets and medicinal chemistry strategies Covers both parasitic and viral diseases with global health impact Underlines emerging therapeutic approaches and SAR-guided design Explains compound screening, optimization, and preclinical research

Zebrafish Models for Experimental Pharmacology: A Handbook is an essential resource for researchers, pharmacologists, and students exploring the expanding role of Zebrafish in drug discovery and experimental pharmacology. The book presents a clear, practical guide to contemporary experimental designs, ethical considerations, animal care, and laboratory techniques specific to Zebrafish models. Key features Comprehensive coverage of drug administration routes, blood collection, and anesthesia techniques in Zebrafish Detailed methodologies for a wide range of behavioral and pharmacological assays, including the Shoaling Test, Novel Diving Tank Test, T-Maze, Y-Maze, Light-Dark Chamber Test, and more Practical guidance on experimental preparation, solution formulation, and tissue handling for in vitro studies Examples and illustrated explanations to support practical implementation in laboratory settings Designed to bridge the gap between foundational research and translational applications, this handbook is a valuable reference for postgraduate students, research scholars, and professionals working in academic, clinical, and industrial pharmacology settings.

Mucosal Vaccine Delivery Systems: The Future of Immunization – Part I presents a pioneering exploration into the realm of mucosal vaccination, covering innovative delivery platforms, immunological mechanisms, and their diverse applications in human and veterinary medicine. This comprehensive volume examines the regulatory, economic, and technological landscapes shaping mucosal vaccine development, highlighting their pivotal role in combating infectious diseases, chronic ailments, and advancing cancer immunotherapy. Key Features: - Detailed insights into nasal, oral, pulmonary, gastrointestinal, and urogenital vaccination. - Analysis of mucosal vaccines in pediatric and elderly healthcare. - Exploration of adjuvants, bioprocessing challenges, and commercialization trends. - Contributions from leading researchers in the field.

Bioactive Compounds Targeting Neurodegenerative Diseases explores the therapeutic potential of natural bioactive compounds in preventing and managing neurodegenerative disorders such as Alzheimer's, Parkinson’s, and Huntington’s disease. The book integrates insights from neuroscience, pharmacognosy, and nanotechnology to highlight innovative strategies for drug delivery and treatment. Chapters cover plant-based bioactives, advanced nano-carriers, intranasal administration, and blood-brain barrier targeting. It also discusses clinical approaches, current treatment challenges, and intellectual property considerations. Key Features: - Comprehensive overview of natural bioactive compounds in neurodegenerative therapy. - Coverage of phytochemicals, nano-delivery systems, and intranasal administration. - Insights into the blood-brain barrier and clinical management strategies. - Discussion on current therapies and intellectual property issues.

Bentham Briefs in Biomedicine and Pharmacotherapy (Volume 3): Anthraquinones: Bioactive Multifaceted Therapeutic Agents discusses the expansive realm of anthraquinones, pivotal aromatic compounds in medicine, biotechnology, and industry. This comprehensive volume integrates traditional knowledge with cutting-edge research, covering biosynthesis, analytical methodologies, therapeutic applications, and industrial uses. Key Features: - Detailed exploration of anthraquinone biosynthesis and bioactivity. - Advanced insights into nanotechnology-driven drug delivery. - Modern extraction techniques and analytical methodologies. - Contributions from leading experts, ensuring rigorous, research-driven content.